Advertisement
News
Advertisement

Bender steps down as CEO of Interleukin

Fri, 08/24/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Interleukin Genetics Inc. (OTCQB: ILIU) announced Friday that Lewis Bender resigned as CEO effective Thursday, and will be replaced by Kenneth Kornman, the company’s founder, president and chief scientific officer.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading